Helping clients meet their business challenges begins with an in-depth understanding of the industries in which they work. That’s why KPMG LLP established its industry-driven structure. In fact, KPMG LLP was the first of the Big Four firms to organize itself along the same industry lines as clients.

How We Work

We bring together passionate problem-solvers, innovative technologies, and full-service capabilities to create opportunity with every insight.

Learn more

Careers & Culture

What is culture? Culture is how we do things around here. It is the combination of a predominant mindset, actions (both big and small) that we all commit to every day, and the underlying processes, programs and systems supporting how work gets done.

Learn more

Effects of the IRA on the pharmaceutical industry

A practical guide for pharmaceutical companies

Effects of the Inflation Reduction Act On the Pharmaceutical Industry

President Biden signed the Inflation Reduction Act (IRA, P.L. 117-169) into law on August 16, 2022, following its passage along party lines in the Senate and House. While the IRA was intended to reduce the deficit and provide funding for major investments in healthcare, domestic energy production, and manufacturing, and to mitigate climate change, there are several provisions with accounting and tax implications relevant to the pharmaceutical industry.

Mark Drozdowski, KPMG Partner and the national life sciences audit leader and Christine Kachinsky-Bye, KPMG Partner and the U.S. life sciences tax industry leader wrote this thought leadership to provide a practical guide to the financial accounting and tax issues a pharmaceutical company might face in its year-end and first-quarter 2023 financial reporting for drug pricing rebates, the newly enacted corporate alternative minimum tax, the excise tax on stock repurchases, and a variety of tax credits.

Dive into our thinking:

Effects of the Inflation Reduction Act on the Pharmaceutical Industry

Download PDF

Explore more insights

Meet our team

Image of Christine Kachinsky
Christine Kachinsky
Life Sciences Tax Industry Leader, KPMG US
Image of Mark Drozdowski
Mark Drozdowski
Partner, National Audit Leader, Life Sciences, KPMG US

Thank you!

Thank you for contacting KPMG. We will respond to you as soon as possible.

Contact KPMG

Use this form to submit general inquiries to KPMG. We will respond to you as soon as possible.

By submitting, you agree that KPMG LLP may process any personal information you provide pursuant to KPMG LLP's Privacy Statement.

An error occurred. Please contact customer support.

Job seekers

Visit our careers section or search our jobs database.

Submit RFP

Use the RFP submission form to detail the services KPMG can help assist you with.

Office locations

International hotline

You can confidentially report concerns to the KPMG International hotline

Press contacts

Do you need to speak with our Press Office? Here's how to get in touch.